Avidity Biosciences, Inc. — Director's Dealing 2025

Jun 19, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Avidity Biosciences, Inc. (RNA)
CIK: 0001599901
Period of Report: 2025-06-17

Reporting Person: Gallagher Kathleen P. (Chief Program Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-06-17	Common Stock	S	911	$30.24	Disposed	50392	Direct

Footnotes

F1: This sale was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 12, 2024.